TTNP Logo

Titan Pharmaceuticals, Inc. (TTNP) 

NASDAQ$3.63+0.04 (1.11%)
Market Cap
$3.28M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
889 of 924
Rank in Industry
507 of 527

TTNP Insider Trading Activity

TTNP Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00–
Sells
$00–

Related Transactions

No records found

About Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the â€¦

Insider Activity of Titan Pharmaceuticals, Inc.

Over the last 12 months, insiders at Titan Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Titan Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Titan Pharmaceuticals, Inc. have bought $795,297 and sold $441,651 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 20,000 shares for transaction amount of $20,066 was made by Lazar David E. (Chief Executive Officer) on 2023‑01‑25.

List of Insider Buy and Sell Transactions, Titan Pharmaceuticals, Inc.

2023-06-21SaleLazar David E.Chief Executive Officer
359,066
3.9347%
$1.23$441,651-49.33%
2023-01-25PurchaseLazar David E.Chief Executive Officer
20,000
0.1494%
$1.00$20,066-43.00%
2023-01-24PurchaseLazar David E.Chief Executive Officer
37,500
0.2755%
$0.97$36,221-40.82%
2022-07-06PurchaseActivist Investing LLC
744,294
5.613%
$0.99$739,010+3.33%
2018-10-19PurchaseRecli Federico Seghidirector
200,000
0.3009%
$0.41$81,680-36.40%
2018-09-24PurchaseRecli Federico Seghidirector
500,000
2.3618%
$0.23$113,800+9.85%
2018-09-21PurchaseRubin MarcExecutive Chairman
400,000
2.107%
$0.25$100,000+10.23%
2018-09-21PurchaseBHONSLE SUNILSee Remarks
300,000
1.5802%
$0.25$75,000+10.23%
2018-09-21PurchaseMCNAB JAMES Rdirector
200,000
1.0535%
$0.25$50,000+10.23%
2018-09-21PurchaseAkers Joseph Adirector
200,000
1.0535%
$0.25$50,000+10.23%
2018-09-21PurchaseMACFARLANE M DAVIDdirector
80,000
0.4214%
$0.25$20,000+10.23%
2016-07-19PurchaseAkers Joseph Adirector
5,000
0.023%
$4.68$23,400-13.54%
2016-07-18PurchaseBHONSLE SUNILPresident and CEO
10,000
0.0474%
$4.96$49,550-15.82%
2016-07-18PurchaseAkers Joseph Adirector
8,000
0.0379%
$4.95$39,600-15.82%
2016-05-31PurchaseMCNAB JAMES Rdirector
20,000
0.0975%
$7.03$140,600-36.70%
2016-02-22PurchaseBHONSLE SUNILPresident and CEO
11,763
0.0596%
$3.56$41,817+42.86%
2016-01-15PurchaseBHONSLE SUNILPresident and CEO
5,841
0.0255%
$2.72$15,888+61.29%
2016-01-13PurchaseMCNAB JAMES Rdirector
16,363
0.0756%
$3.16$51,707+46.63%
2016-01-11PurchaseRubin MarcExecutive Chairman
5,000
0.027%
$3.25$16,250+66.67%
2016-01-11PurchaseBHONSLE SUNILPresident and CEO
17,000
0.0898%
$3.18$54,060+66.67%
Total: 85

Insider Historical Profitability

3.33%
Activist Investing LLC
3331402
364.3927%
$11.96M10+3.33%
Recli Federico Seghidirector
800845
87.5974%
$2.88M20
Rubin MarcExecutive Chairman
556317
60.8506%
$2M90
BUCALO LOUIS R MDPresident and CEO
550000
60.1597%
$1.97M50
Kapp Joachim Friedrichdirector
546339
59.7592%
$1.96M125

Historical Insider Profitability vs. Competitors

$18,881,323
88
-48.96%
$3.75M
$296,936
37
-18.12%
$4.42M
$1,138,733
28
-4.94%
$2.7M
$1,616,354
20
-12.22%
$3.22M
$960,082
17
-6.29%
$3.61M

TTNP Institutional Investors: Active Positions

Increased Positions<1+5%<1+<0.01%
Decreased Positions5-25%13,919-82.86%
New Positions<1New<1New
Sold Out Positions2Sold Out11,809Sold Out
Total Postitions16-20%2,880-82.86%

TTNP Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Ubs Group Ag$11.000.27%2,667-2,106-44.12%2024-12-31
Mcf Advisors Llc$1.000.02%16500%2024-12-31
Bank Of America Corp /De/$0<0.01%1700%2024-12-31
Group One Trading Llc$0<0.01%1200%2024-12-31
Osaic Holdings, Inc.$0<0.01%7-3-30%2024-12-31
Morgan Stanley$00%3<1-25%2024-12-31
Global Wealth Strategies & Associates$00%200%2024-12-31
Nemes Rush Group Llc$00%100%2024-12-31
Caldwell Sutter Capital, Inc.$00%100%2024-12-31
Cape Investment Advisory, Inc.$00%100%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.